Nociception & Analgesia Monitoring Patents: Leaders, Trends 2026
Nociception and Analgesia Monitoring Patents: Who Holds the Ground
Filing peaked in 2021 at 11 records and fell to zero by 2024 — a complete three-year swing, not a slowdown still in progress. Filing rose to a peak of 11 records in 2021, then declined to 0 by 2024 — a documented -100% swing across that three-year span. Because 2024 is the most recent year that can be treated as complete, that fall is the reliable read; 2025 and later are still filling in and should not be read as continued decline.
- 1柯惠LP公司13
- 2美达森斯生物测定有限公司6
- 3通用电气医疗芬兰公司3
- 4美敦力公司3
- 5SEITZ ZACH1
See the full nociception and analgesia monitoring analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about this landscape
What counts as a nociception monitoring patent?
In this landscape, a record qualifies if it names nociception monitoring or an analgesia index directly and pairs that with at least one recognised physiological signal source, such as heart rate variability, skin conductance, or pupillometry. This narrows the scope to devices and software that infer a patient’s pain or analgesic state from measurable signals, rather than any general pain-management patent. The 26 records in this set were identified on that basis across a coverage window from 2015 to mid-2026.
Why did nociception monitoring patent filings fall after 2021?
Filing activity peaked at 11 records in 2021 and had fallen to 0 by 2024, a documented -100% swing across that span. That drop should be read as a completed filing cycle rather than an industry retreat, since 2024 is the most recent year in this dataset that can be treated as complete. Filings from 2025 onward are still being published, so it is too early to say whether the field has genuinely gone quiet or is simply under-reported so far.
Who are the leading patent holders in nociception and analgesia monitoring?
The ranking in this dataset covers 10 assignees, with the leader holding 13 of the 26 records in scope — roughly half the field by volume. Beyond that leader, holdings drop off quickly, with the fifth-ranked assignee holding just 1 record and the tenth also holding 1. A specialist device maker and a cluster of individually named co-filing inventors round out the rest of the ranked list.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Nociception and Analgesia Monitoring covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.